EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

Development and Initial Analytical Evaluation of a Multiplex PCR-Based Targeted NGS Assay for Expanded Viral Detection in Clinical Respiratory Specimens

Maksim I. Nadtoka, Anna Y. Bukharina, German V. Roev, Arina V. Peresadina, Anastasiia V. Vykhodtseva, Matvei R. Agletdinov, Sergey E. Goncharov, Ekaterina V. Pimkina, Elmira R. Samitova, Margarita D. Khaldeeva, Ruslan F. Sayfullin, Yana A. Voytsekhovskaya, Anna S. Cherkashina, Alexander E. Kuznetsov, Kamil F. Khafizov, Vasiliy G. Akimkin

Diagnostics · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Background: The diagnosis of infectious diseases currently relies predominantly on polymerase chain reaction (PCR) assays. However, the range of pathogens that can be detected simultaneously using these methods is limited, and their effective use depends on an a priori etiological hypothesis. Multiplex PCR-based targeted next-generation sequencing (mp-tNGS) is considered a promising complementary approach for expanded viral testing. This study aimed to develop an in-house mp-tNGS method, perform an initial evaluation of its analytical sensitivity, and explore its performance using clinical respiratory specimens. Methods: The method comprised a panel targeting 28 viruses and bioinformatics pipelines for mp-tNGS data processing. Analytical sensitivity was evaluated using positive control samples (PCSs) containing encapsulated RNA or DNA. Performance with clinical specimens was explored using 910 nasopharyngeal and oropharyngeal swab specimens, which were divided into three groups based on the results of prior PCR testing. Results: Of the 28 viral targets, 23 underwent experimental analytical evaluation, whereas five were assessed in silico only. For 19 of the 23 PCSs tested, the estimated limit of detection (LoD) ranged from 6.3 × 102 to 9.4 × 103 copies/mL. In the group of 216 PCR-positive specimens, PCR and mp-tNGS results were fully concordant in 139 cases; in 28 specimens, mp-tNGS additionally detected other viruses. Among 394 PCR-negative specimens, mp-tNGS detected viruses in 81. In the group of 300 hospital-derived specimens, mp-tNGS detected at least one viral target in 131 specimens, including additional viral detections and coinfections not identified during the initial testing. A substantial proportion of the additional findings involved Epstein–Barr virus (EBV) and cytomegalovirus (CMV), warranting cautious clinical interpretation. Conclusions: The developed mp-tNGS approach demonstrated the potential to simultaneously detect a broad range of known viruses, provide viral typing, and identify coinfections. The method may be used as an adjunctive tool to broaden the laboratory diagnosis of respiratory infections; however, further optimization, validation, and standardization of criteria for result interpretation are required.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Maksim I. Nadtoka, Anna Y. Bukharina, German V. Roev, Arina V. Peresadina, Anastasiia V. Vykhodtseva, Matvei R. Agletdinov, Sergey E. Goncharov, Ekaterina V. Pimkina, Elmira R. Samitova, Margarita D. Khaldeeva, Ruslan F. Sayfullin, Yana A. Voytsekhovskaya, Anna S. Cherkashina, Alexander E. Kuznetsov, Kamil F. Khafizov, Vasiliy G. Akimkin
Quelle
Diagnostics
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
2075-4418
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Maksim I. Nadtoka, Anna Y. Bukharina, German V. Roev, Arina V. Peresadina, Anastasiia V. Vykhodtseva, Matvei R. Agletdinov, Sergey E. Goncharov, Ekaterina V. Pimkina, Elmira R. Samitova, Margarita D. Khaldeeva, Ruslan F. Sayfullin, Yana A. Voytsekhovskaya, Anna S. Cherkashina, Alexander E. Kuznetsov, Kamil F. Khafizov, Vasiliy G. Akimkin (2026). Development and Initial Analytical Evaluation of a Multiplex PCR-Based Targeted NGS Assay for Expanded Viral Detection in Clinical Respiratory Specimens. Diagnostics. https://doi.org/10.3390/diagnostics16182888
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1